Frontlight ResearchEarly access
Trial site
Velocity Clinical Research GmbH
- 5running trials
- 19closed trials
The trials here
What the 24 trials at this site are about, from their registry records.
- Conditions
- Obesity5 trials
- Asthma4 trials
- COPD4 trials
- Familial hypercholesterolaemia3 trials
- Heart failure3 trials
- Type 2 diabetes2 trials
- Chronic kidney disease1 trial
- Coronary artery disease1 trial
- Diabetic neuropathy1 trial
- Insomnia1 trial
- Irritable bowel syndrome1 trial
- Osteoarthritis1 trial
- and 1 more
- Phase
- Phase 312 trials
- Phase 29 trials
- Phase 42 trials
- Phase 11 trial
- Status
- Completed19 trials
- Active, not recruiting4 trials
- Recruiting1 trial
- Lead sponsor
- AstraZeneca6 trials
- Amgen3 trials
- Chiesi Farmaceutici S.p.A.2 trials
- Merck Sharp & Dohme LLC2 trials
- Novartis Pharma AG2 trials
- and 9 more
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Irritable bowel syndrome1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
A proof of concept and dose-finding study of XXB750 in patients with heart failure
Completed
Completed
Completed
Completed
Completed
Completed
Efficacy and Tolerability of Tasipimidine in Sleepless Patients
Completed
Completed
Completed
Completed
Study of Efficacy, Safety and Tolerability of DFV890 in Patients With Knee Osteoarthritis
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026